Lecture 4: Antigen Presentation by T lymphocytes Questions to - - PowerPoint PPT Presentation

lecture 4 antigen presentation by t lymphocytes
SMART_READER_LITE
LIVE PREVIEW

Lecture 4: Antigen Presentation by T lymphocytes Questions to - - PowerPoint PPT Presentation

Lecture 4: Antigen Presentation by T lymphocytes Questions to Consider What is the structural basis by which MHC molecules present peptides to the T cell receptor? How are endogenous peptides targeted to MHC Class I molecules and


slide-1
SLIDE 1

Lecture 4: Antigen Presentation by T lymphocytes

slide-2
SLIDE 2

Questions to Consider

What is the structural basis by which MHC molecules present peptides to the T cell receptor?

How are endogenous peptides targeted to MHC Class I molecules and exogenous peptides targeted to MHC Class II molecules?

How does the T cell receptor see the peptide and MHC molecule?

What is the structural basis for CD4 T cells/MHC Class II and CD8 T cell/MHC Class I restriction?

slide-3
SLIDE 3

Presentation of Peptide to CD8 or CD4 T Cell by Class I MHC or Class II MHC Molecules, Respectively

slide-4
SLIDE 4

The Three Loci Encoding MHC Class I (A, B and C) or MHC Class II (DP, DQ or DR) Genes Are Highly Polymorphic

Number of alleles/locus

slide-5
SLIDE 5

Expression of MHC Alleles is Codominant

slide-6
SLIDE 6

Class I MHC molecules can present a diverse yet limited number of peptides sized 8 – 10 amino acids long. What is the structural basis that limits the peptides that the MHC molecule can present?

slide-7
SLIDE 7

Structure of MHC Class I Molecule

Heterodimer of membrane- spanning -chain and 2-microglobulin

The -chain is polymorphic while the 2-microglobulin is the same for everyone

The 1 and 2 domains form a cleft or pocket able to non- covalently bind peptides

slide-8
SLIDE 8

Peptides Are Bound Within MHC Class I Molecules by Hydrogen Bonds and Ionic Interactions Between Amino Acids in the Peptide Ends and the MHC Molecule

slide-9
SLIDE 9

Polymorphism in the MHC Molecules is Restricted to the Peptide-Binding Cleft

slide-10
SLIDE 10

Peptides Bind to MHC Class I Molecules Through Anchor Residues Unique for Each MHC Molecule

slide-11
SLIDE 11

Structural Basis For the Tight Binding of Peptides: Limited in Length Within the MHC Class I Cleft

slide-12
SLIDE 12

Some Residues of the Peptide in the MHC Molecule Are Aligned Toward MHC Binding Clefts and Others Toward the T Cell Receptor

From Dr. Stanley Nathenson

slide-13
SLIDE 13

Structural Representation of Anchor Residue Binding of Peptides Within the MHC Cleft

MHC Class I molecule Peptide Anchor Residues T cell epitopes

From Dr. Stanley Nathenson

slide-14
SLIDE 14

What is the structural basis permitting MHC Class II molecules to present longer peptides than MHC Class I molecules? MHC Class II molecules can present a diverse yet limited number of peptides sized 13 – 17 amino acids long.

slide-15
SLIDE 15

Structure of MHC Class II Molecule

Heterodimer of membrane-spanning -chain and -chain

The -chain and - chain are polymorphic

The 1 and 1 domains form a cleft

  • r pocket able to non-

covalently bind peptides

slide-16
SLIDE 16

Part of the Peptide Is Bound to MHC Class II Molecules by Hydrogen Bonds and Ionic Interactions Between Amino Acids in the Peptide and the MHC Molecule

slide-17
SLIDE 17

Peptides of Variable Length Bind to MHC Class II Molecules Through Structurally Related Anchor Residues At Various Distances From the Ends of the Peptide

Position 9 is hydrophobic tyrosine (Y), leucine (L), proline (P) or phenylalanine (F). Position 4 is negatively charged aspartic acid (D) or glutamic acid (E) Position 1 has hydrophobic residues

slide-18
SLIDE 18

Class I MHC or Class II MHC Molecules Present Peptides to CD8 or CD4 T Cells Respectively

slide-19
SLIDE 19

MHC Molecules Contain Binding Sites For Either CD4 or CD8

slide-20
SLIDE 20

Structural Differences between Class I MHC and Class II MHC Molecules and Their Consequences

Class I MHC Class II MHC Structure -chain and 2-microglobulin -chain and -chain Peptide size 8-9 amino acids 13-17 amino acids Cleft Peptide must be within cleft Ends of peptide can dangle

  • utside of cleft

Binding affinity Peptide tightly bound Peptide is bound looser T cell interaction CD8+ T cell CD4+ T cell

slide-21
SLIDE 21

How do peptides get into those clefts and what are the functional ramifications

  • f this process?

Remember that presentation

  • f a foreign peptide in a

Class I MHC molecule to a CD8 T cell is a death sentence

slide-22
SLIDE 22

Cells Contain Two Intracellular Compartments: The Vesicular Which Communicates With the Extracellular Fluid and Cytosol Which Does Not

slide-23
SLIDE 23

The Compartmental Localization of Pathogen Determines the Destination of Its Peptides

slide-24
SLIDE 24

Peptides Presented by MHC Class I Molecules Are Derived From Intracellular Proteins

slide-25
SLIDE 25

The Proteosome Generates Peptides of Equivalent Size From Proteins

slide-26
SLIDE 26

The TAP Molecule Transports Peptides Into the Lumen of the Endoplasmic Reticulum

slide-27
SLIDE 27

Cytosolic Proteins Are Degraded and Transported Into the ER Where They Can Bind to MHC Class I Molecules

slide-28
SLIDE 28

Peptides Presented by MHC Class II Molecules Are Derived From Extracellular Proteins

slide-29
SLIDE 29

The Phagolysosome Generates Peptides

  • f Different Sizes From Proteins
slide-30
SLIDE 30

MHC Class II Molecules Are Exported From the ER With Its Cleft Containing the Invariant Chain

slide-31
SLIDE 31

Processing of Invariant Chain to CLIP Peptide

slide-32
SLIDE 32

Peptides Derived From Exogenous Antigen Replace the CLIP Peptide in the MHC Class II Molecule Cleft in the Endosome

slide-33
SLIDE 33

Class I MHC or Class II MHC Molecules Present Peptides to CD8 or CD4 T Cells Respectively

slide-34
SLIDE 34

The T Cell Receptor Specifically Recognizes Sequences in the MHC Molecule and the Peptide it is Presenting

slide-35
SLIDE 35

Alloreactivity May Be Due to Heightened Affinity of a T Cell Receptor to a Different Nonself Peptide Alone or a Nonself Foreign MHC Molecule Alone

slide-36
SLIDE 36

Differences Between Peptide Processing

  • f Class I and Class II MHC Molecules

Class I MHC Class II MHC Peptide Source Endogenous Exogenous Peptide loading Endoplasmic reticulum Endosome Peptide used for folding Antigen-derived peptide CLIP peptide T cell interaction CD8+ T cell CD4+ T cell Cellular sequela of presentation Death Activation

slide-37
SLIDE 37

Tetramers Can Identify and Quantify Ag-specific T Cells

slide-38
SLIDE 38

MMWR May 23 1980 (1980; 29: 229-30)

National surveillance data, first MMWR report

55 cases of TSS from 8 states; 31 from Wisconsin

52 (95%) cases in women

38 (95%) of 40 (known history) onset during menses

33 (73%) of 45 had S. aureus isolated from mucosal site

Case fatality rates: 13% overall: 3.2% (1/31) in Wisconsin, 25% (6/24) in 7 other states

slide-39
SLIDE 39

Necrotizing Rash Associated With Toxic Shock Syndrome

slide-40
SLIDE 40

Superantigens Bind Directly to the TCR and Activate T Cells

slide-41
SLIDE 41

Immunological Synapse

From Grakoui, et al Science ,1999 Vol 285, 221-227

slide-42
SLIDE 42

The Immunological Synapse is Characterized by a Ring of Adhesion Molecules Surrounding T cell Receptor-associated Molecules

slide-43
SLIDE 43

HIV Co-opts The Immunological Synapse to Enhance Cell-to-cell Transmission

Env

J Clin Invest. 2004; 114(5):605

slide-44
SLIDE 44

Questions to Consider

What is the structural basis by which MHC molecules present peptides to the T cell receptor?

How are endogenous peptides targeted to MHC Class I molecules and exogenous peptides targeted to MHC Class II molecules?

How does the T cell receptor see the peptide and MHC molecule?

What is the structural basis for CD4 T cells/MHC Class II and CD8 T cell/MHC Class I restriction?